Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,147
archived clinical trials in
Asthma

A Single Ascending Dose Study of R1671 in Patients With Mild Intermittent Asymptomatic Asthma.
A Randomized, Double-blind, Single Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Effect on Pharmacodynamic Biomarkers of an Intravenous Infusion of R1671 in Patients With Mild, Intermittent Asymptomatic Asthma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Little Rock, AR
A Single Ascending Dose Study of R1671 in Patients With Mild Intermittent Asymptomatic Asthma.
A Randomized, Double-blind, Single Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Effect on Pharmacodynamic Biomarkers of an Intravenous Infusion of R1671 in Patients With Mild, Intermittent Asymptomatic Asthma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Single Ascending Dose Study of R1671 in Patients With Mild Intermittent Asymptomatic Asthma.
A Randomized, Double-blind, Single Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Effect on Pharmacodynamic Biomarkers of an Intravenous Infusion of R1671 in Patients With Mild, Intermittent Asymptomatic Asthma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
North Hollywood, CA
A Single Ascending Dose Study of R1671 in Patients With Mild Intermittent Asymptomatic Asthma.
A Randomized, Double-blind, Single Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Effect on Pharmacodynamic Biomarkers of an Intravenous Infusion of R1671 in Patients With Mild, Intermittent Asymptomatic Asthma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
North Hollywood, CA
Click here to add this to my saved trials
A Single Ascending Dose Study of R1671 in Patients With Mild Intermittent Asymptomatic Asthma.
A Randomized, Double-blind, Single Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Effect on Pharmacodynamic Biomarkers of an Intravenous Infusion of R1671 in Patients With Mild, Intermittent Asymptomatic Asthma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Port Orange, FL
A Single Ascending Dose Study of R1671 in Patients With Mild Intermittent Asymptomatic Asthma.
A Randomized, Double-blind, Single Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Effect on Pharmacodynamic Biomarkers of an Intravenous Infusion of R1671 in Patients With Mild, Intermittent Asymptomatic Asthma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Port Orange, FL
Click here to add this to my saved trials
A Single Ascending Dose Study of R1671 in Patients With Mild Intermittent Asymptomatic Asthma.
A Randomized, Double-blind, Single Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Effect on Pharmacodynamic Biomarkers of an Intravenous Infusion of R1671 in Patients With Mild, Intermittent Asymptomatic Asthma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Normal, IL
A Single Ascending Dose Study of R1671 in Patients With Mild Intermittent Asymptomatic Asthma.
A Randomized, Double-blind, Single Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Effect on Pharmacodynamic Biomarkers of an Intravenous Infusion of R1671 in Patients With Mild, Intermittent Asymptomatic Asthma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Normal, IL
Click here to add this to my saved trials
A Single Ascending Dose Study of R1671 in Patients With Mild Intermittent Asymptomatic Asthma.
A Randomized, Double-blind, Single Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Effect on Pharmacodynamic Biomarkers of an Intravenous Infusion of R1671 in Patients With Mild, Intermittent Asymptomatic Asthma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Madisonville, KY
A Single Ascending Dose Study of R1671 in Patients With Mild Intermittent Asymptomatic Asthma.
A Randomized, Double-blind, Single Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Effect on Pharmacodynamic Biomarkers of an Intravenous Infusion of R1671 in Patients With Mild, Intermittent Asymptomatic Asthma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Madisonville, KY
Click here to add this to my saved trials
A Single Ascending Dose Study of R1671 in Patients With Mild Intermittent Asymptomatic Asthma.
A Randomized, Double-blind, Single Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Effect on Pharmacodynamic Biomarkers of an Intravenous Infusion of R1671 in Patients With Mild, Intermittent Asymptomatic Asthma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
North Dartmouth, MA
A Single Ascending Dose Study of R1671 in Patients With Mild Intermittent Asymptomatic Asthma.
A Randomized, Double-blind, Single Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Effect on Pharmacodynamic Biomarkers of an Intravenous Infusion of R1671 in Patients With Mild, Intermittent Asymptomatic Asthma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
North Dartmouth, MA
Click here to add this to my saved trials
A Single Ascending Dose Study of R1671 in Patients With Mild Intermittent Asymptomatic Asthma.
A Randomized, Double-blind, Single Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Effect on Pharmacodynamic Biomarkers of an Intravenous Infusion of R1671 in Patients With Mild, Intermittent Asymptomatic Asthma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Morrisville, NC
A Single Ascending Dose Study of R1671 in Patients With Mild Intermittent Asymptomatic Asthma.
A Randomized, Double-blind, Single Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Effect on Pharmacodynamic Biomarkers of an Intravenous Infusion of R1671 in Patients With Mild, Intermittent Asymptomatic Asthma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Morrisville, NC
Click here to add this to my saved trials
A Single Ascending Dose Study of R1671 in Patients With Mild Intermittent Asymptomatic Asthma.
A Randomized, Double-blind, Single Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Effect on Pharmacodynamic Biomarkers of an Intravenous Infusion of R1671 in Patients With Mild, Intermittent Asymptomatic Asthma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
San Antonio, TX
A Single Ascending Dose Study of R1671 in Patients With Mild Intermittent Asymptomatic Asthma.
A Randomized, Double-blind, Single Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Effect on Pharmacodynamic Biomarkers of an Intravenous Infusion of R1671 in Patients With Mild, Intermittent Asymptomatic Asthma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Long-term Safety Study of QGE031 in Patients With Allergic Asthma Who Completed Study CQGE031B2201
An Open-label, Multi-center, Extension Study to Evaluate the Long-term Safety of Subcutaneous 240mg QGE031 Given Every 4 Weeks for 52 Weeks in Allergic Asthma Patients Who Completed Study CQGE031B2201
Status: Enrolling
Updated:  8/2/2016
Novartis Investigator Site
mi
from
Evansville, IN
Long-term Safety Study of QGE031 in Patients With Allergic Asthma Who Completed Study CQGE031B2201
An Open-label, Multi-center, Extension Study to Evaluate the Long-term Safety of Subcutaneous 240mg QGE031 Given Every 4 Weeks for 52 Weeks in Allergic Asthma Patients Who Completed Study CQGE031B2201
Status: Enrolling
Updated: 8/2/2016
Novartis Investigator Site
mi
from
Evansville, IN
Click here to add this to my saved trials
Long-term Safety Study of QGE031 in Patients With Allergic Asthma Who Completed Study CQGE031B2201
An Open-label, Multi-center, Extension Study to Evaluate the Long-term Safety of Subcutaneous 240mg QGE031 Given Every 4 Weeks for 52 Weeks in Allergic Asthma Patients Who Completed Study CQGE031B2201
Status: Enrolling
Updated:  8/2/2016
Novartis Investigator Site
mi
from
Owensboro, KY
Long-term Safety Study of QGE031 in Patients With Allergic Asthma Who Completed Study CQGE031B2201
An Open-label, Multi-center, Extension Study to Evaluate the Long-term Safety of Subcutaneous 240mg QGE031 Given Every 4 Weeks for 52 Weeks in Allergic Asthma Patients Who Completed Study CQGE031B2201
Status: Enrolling
Updated: 8/2/2016
Novartis Investigator Site
mi
from
Owensboro, KY
Click here to add this to my saved trials
Long-term Safety Study of QGE031 in Patients With Allergic Asthma Who Completed Study CQGE031B2201
An Open-label, Multi-center, Extension Study to Evaluate the Long-term Safety of Subcutaneous 240mg QGE031 Given Every 4 Weeks for 52 Weeks in Allergic Asthma Patients Who Completed Study CQGE031B2201
Status: Enrolling
Updated:  8/2/2016
Novartis Investigative Site
mi
from
Waldorf, MD
Long-term Safety Study of QGE031 in Patients With Allergic Asthma Who Completed Study CQGE031B2201
An Open-label, Multi-center, Extension Study to Evaluate the Long-term Safety of Subcutaneous 240mg QGE031 Given Every 4 Weeks for 52 Weeks in Allergic Asthma Patients Who Completed Study CQGE031B2201
Status: Enrolling
Updated: 8/2/2016
Novartis Investigative Site
mi
from
Waldorf, MD
Click here to add this to my saved trials
Long-term Safety Study of QGE031 in Patients With Allergic Asthma Who Completed Study CQGE031B2201
An Open-label, Multi-center, Extension Study to Evaluate the Long-term Safety of Subcutaneous 240mg QGE031 Given Every 4 Weeks for 52 Weeks in Allergic Asthma Patients Who Completed Study CQGE031B2201
Status: Enrolling
Updated:  8/2/2016
Novartis Investigator Site
mi
from
Minneapolis, MN
Long-term Safety Study of QGE031 in Patients With Allergic Asthma Who Completed Study CQGE031B2201
An Open-label, Multi-center, Extension Study to Evaluate the Long-term Safety of Subcutaneous 240mg QGE031 Given Every 4 Weeks for 52 Weeks in Allergic Asthma Patients Who Completed Study CQGE031B2201
Status: Enrolling
Updated: 8/2/2016
Novartis Investigator Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Long-term Safety Study of QGE031 in Patients With Allergic Asthma Who Completed Study CQGE031B2201
An Open-label, Multi-center, Extension Study to Evaluate the Long-term Safety of Subcutaneous 240mg QGE031 Given Every 4 Weeks for 52 Weeks in Allergic Asthma Patients Who Completed Study CQGE031B2201
Status: Enrolling
Updated:  8/2/2016
Novartis
mi
from
Fairfax, VA
Long-term Safety Study of QGE031 in Patients With Allergic Asthma Who Completed Study CQGE031B2201
An Open-label, Multi-center, Extension Study to Evaluate the Long-term Safety of Subcutaneous 240mg QGE031 Given Every 4 Weeks for 52 Weeks in Allergic Asthma Patients Who Completed Study CQGE031B2201
Status: Enrolling
Updated: 8/2/2016
Novartis
mi
from
Fairfax, VA
Click here to add this to my saved trials
Long-term Safety Study of QGE031 in Patients With Allergic Asthma Who Completed Study CQGE031B2201
An Open-label, Multi-center, Extension Study to Evaluate the Long-term Safety of Subcutaneous 240mg QGE031 Given Every 4 Weeks for 52 Weeks in Allergic Asthma Patients Who Completed Study CQGE031B2201
Status: Enrolling
Updated:  8/2/2016
Novartis Investigative Site
mi
from
Caba,
Long-term Safety Study of QGE031 in Patients With Allergic Asthma Who Completed Study CQGE031B2201
An Open-label, Multi-center, Extension Study to Evaluate the Long-term Safety of Subcutaneous 240mg QGE031 Given Every 4 Weeks for 52 Weeks in Allergic Asthma Patients Who Completed Study CQGE031B2201
Status: Enrolling
Updated: 8/2/2016
Novartis Investigative Site
mi
from
Caba,
Click here to add this to my saved trials
Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow
Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow
Status: Enrolling
Updated:  8/15/2016
University of Missouri, Department of Internal Medicine
mi
from
Columbia, MO
Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow
Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow
Status: Enrolling
Updated: 8/15/2016
University of Missouri, Department of Internal Medicine
mi
from
Columbia, MO
Click here to add this to my saved trials
Multisystemic Therapy to Reduce Health Disparities in Adolescents With Asthma
Multisystemic Therapy to Reduce Health Disparities in Adolescents With Asthma
Status: Enrolling
Updated:  8/18/2016
Wayne State University School of Medicine
mi
from
Detroit, MI
Multisystemic Therapy to Reduce Health Disparities in Adolescents With Asthma
Multisystemic Therapy to Reduce Health Disparities in Adolescents With Asthma
Status: Enrolling
Updated: 8/18/2016
Wayne State University School of Medicine
mi
from
Detroit, MI
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Hoover, AL
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Hoover, AL
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Fort Mohave, AZ
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Fort Mohave, AZ
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Jonesboro, AR
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Jonesboro, AR
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Alhambra, CA
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Alhambra, CA
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Huntington Beach, CA
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Paramount, CA
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Paramount, CA
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Denver, CO
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Denver, CO
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Clearwater, FL
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Clearwater, FL
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Atlanta, GA
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Savannah, GA
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Savannah, GA
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
DeKalb, IL
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
DeKalb, IL
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Mandeville, LA
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Mandeville, LA
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Metairie, LA
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Metairie, LA
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Boston, MA
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Kansas City, MO
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Kansas City, MO
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
St. Louis, MO
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
St. Louis, MO
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Alliance, NE
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Alliance, NE
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Johnson City, NY
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Johnson City, NY
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Utica, NY
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Utica, NY
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Columbus, OH
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Dayton, OH
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Dayton, OH
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Huber Heights, OH
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Huber Heights, OH
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Hershey, PA
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Hershey, PA
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Pittsburgh, PA
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Dallas, TX
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Houston, TX
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Vienna, VA
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Vienna, VA
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Hato Rey,
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Hato Rey,
Click here to add this to my saved trials
Supervised Asthma Medication in Schools (SAMS)
The Cost Effectiveness of School-Based Supervised Asthma Therapy
Status: Enrolling
Updated:  10/25/2016
The University of Arizona and the Tucson Unified School District
mi
from
Tucson, AZ
Supervised Asthma Medication in Schools (SAMS)
The Cost Effectiveness of School-Based Supervised Asthma Therapy
Status: Enrolling
Updated: 10/25/2016
The University of Arizona and the Tucson Unified School District
mi
from
Tucson, AZ
Click here to add this to my saved trials
Protein Biomarker Discovery and Validation in Chronic Obstructive Pulmonary Disease (COPD) And Asthma
Protein Biomarker Discovery and Validation in COPD And Asthma
Status: Enrolling
Updated:  11/2/2016
University of Texas Medical Branch
mi
from
Galveston, TX
Protein Biomarker Discovery and Validation in Chronic Obstructive Pulmonary Disease (COPD) And Asthma
Protein Biomarker Discovery and Validation in COPD And Asthma
Status: Enrolling
Updated: 11/2/2016
University of Texas Medical Branch
mi
from
Galveston, TX
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Alabama, AL
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Alabama, AL
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Arizona, AZ
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Arizona, AZ
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Arkansas, AR
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Arkansas, AR
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in California, CA
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in California, CA
Click here to add this to my saved trials